Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Research Report 2021

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Research Report 2021

Table of Contents
1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Overview
1.1 Product Overview and Scope of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
1.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Type
1.2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Live Vaccine
1.2.3 Inactivated Vaccine
1.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Segment by Application
1.3.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Comparison by Application: (2021-2027)
1.3.2 Government Tender
1.3.3 Marketing
1.4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size Estimates and Forecasts
1.4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue 2016-2027
1.4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales 2016-2027
1.4.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competition by Manufacturers
2.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites, Area Served, Product Type
2.5 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Competitive Situation and Trends
2.5.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Players Market Share by Revenue
2.5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario by Region
3.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.3.1 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.3.2 North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.4.1 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.4.2 Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Region
3.5.1 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region
3.5.2 Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.6.1 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.6.2 Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Facts & Figures by Country
3.7.1 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country
3.7.2 Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Type
4.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
4.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Type (2016-2021)
4.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Type (2016-2021)
5 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Historic Market Analysis by Application
5.1 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
5.2 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Application (2016-2021)
5.3 Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 CNADC
6.1.1 CNADC Corporation Information
6.1.2 CNADC Description and Business Overview
6.1.3 CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CNADC Product Portfolio
6.1.5 CNADC Recent Developments/Updates
6.2 Boehringer-Ingelheim
6.2.1 Boehringer-Ingelheim Corporation Information
6.2.2 Boehringer-Ingelheim Description and Business Overview
6.2.3 Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boehringer-Ingelheim Product Portfolio
6.2.5 Boehringer-Ingelheim Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 MSD Animal Health Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Sinopharm
6.4.1 Sinopharm Corporation Information
6.4.2 Sinopharm Description and Business Overview
6.4.3 Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sinopharm Product Portfolio
6.4.5 Sinopharm Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Ceva Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 Chengdu Tianbang Biological Products Co., Ltd.
6.6.1 Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
6.6.2 Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
6.6.3 Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Chengdu Tianbang Biological Products Co., Ltd. Product Portfolio
6.6.5 Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
6.7 Tianjin Ruipu Biological Technology Co., Ltd.
6.6.1 Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
6.6.2 Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
6.6.3 Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Tianjin Ruipu Biological Technology Co., Ltd. Product Portfolio
6.7.5 Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
6.8 Qilu Animal Health
6.8.1 Qilu Animal Health Corporation Information
6.8.2 Qilu Animal Health Description and Business Overview
6.8.3 Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Qilu Animal Health Product Portfolio
6.8.5 Qilu Animal Health Recent Developments/Updates
6.9 Guangdong Wens Dahuanong Biotechnology Co., Ltd.
6.9.1 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
6.9.2 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
6.9.3 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Product Portfolio
6.9.5 Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
6.10 CAVAC
6.10.1 CAVAC Corporation Information
6.10.2 CAVAC Description and Business Overview
6.10.3 CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 CAVAC Product Portfolio
6.10.5 CAVAC Recent Developments/Updates
6.11 Komipharm
6.11.1 Komipharm Corporation Information
6.11.2 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.11.3 Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Komipharm Product Portfolio
6.11.5 Komipharm Recent Developments/Updates
6.12 Agrovet
6.12.1 Agrovet Corporation Information
6.12.2 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.12.3 Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Agrovet Product Portfolio
6.12.5 Agrovet Recent Developments/Updates
6.13 Bioveta
6.13.1 Bioveta Corporation Information
6.13.2 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.13.3 Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Bioveta Product Portfolio
6.13.5 Bioveta Recent Developments/Updates
6.14 Jinyu Bio-Technology
6.14.1 Jinyu Bio-Technology Corporation Information
6.14.2 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.14.3 Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Jinyu Bio-Technology Product Portfolio
6.14.5 Jinyu Bio-Technology Recent Developments/Updates
6.15 Phibro Animal Health
6.15.1 Phibro Animal Health Corporation Information
6.15.2 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.15.3 Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Phibro Animal Health Product Portfolio
6.15.5 Phibro Animal Health Recent Developments/Updates
6.16 Tiankang
6.16.1 Tiankang Corporation Information
6.16.2 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.16.3 Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Tiankang Product Portfolio
6.16.5 Tiankang Recent Developments/Updates
6.17 Zoetis
6.17.1 Zoetis Corporation Information
6.17.2 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.17.3 Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Zoetis Product Portfolio
6.17.5 Zoetis Recent Developments/Updates
6.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd
6.18.1 Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
6.18.2 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.18.3 Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Guangdong Yongshun Biological Pharmaceutical Co Ltd Product Portfolio
6.18.5 Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
6.19 Plec Bioengineering Co., Ltd.
6.19.1 Plec Bioengineering Co., Ltd. Corporation Information
6.19.2 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Description and Business Overview
6.19.3 Plec Bioengineering Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Plec Bioengineering Co., Ltd. Product Portfolio
6.19.5 Plec Bioengineering Co., Ltd. Recent Developments/Updates
7 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Cost Analysis
7.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS)
7.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Distributors List
8.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Customers
9 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Dynamics
9.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Industry Trends
9.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Growth Drivers
9.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Challenges
9.4 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Restraints
10 Global Market Forecast
10.1 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Type (2022-2027)
10.2 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Application (2022-2027)
10.3 Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Covered in This Study
Table 5. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Share by Manufacturers (2016-2021)
Table 7. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturing Sites and Area Served
Table 11. Manufacturers Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product Type
Table 12. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2016-2021) & (K Units)
Table 16. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Table 17. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 19. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 20. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 22. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 24. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 32. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Market Share by Country (2016-2021)
Table 38. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Type (2016-2021)
Table 39. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Type (2016-2021)
Table 40. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Type (2016-2021)
Table 42. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Type (2016-2021)
Table 43. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units) by Application (2016-2021)
Table 44. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales Market Share by Application (2016-2021)
Table 45. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Revenue Share by Application (2016-2021)
Table 47. Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Price (US$/Unit) by Application (2016-2021)
Table 48. CNADC Corporation Information
Table 49. CNADC Description and Business Overview
Table 50. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. CNADC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 52. CNADC Recent Developments/Updates
Table 53. Boehringer-Ingelheim Corporation Information
Table 54. Boehringer-Ingelheim Description and Business Overview
Table 55. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Boehringer-Ingelheim Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 57. Boehringer-Ingelheim Recent Developments/Updates
Table 58. MSD Animal Health Corporation Information
Table 59. MSD Animal Health Description and Business Overview
Table 60. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. MSD Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 62. MSD Animal Health Recent Developments/Updates
Table 63. Sinopharm Corporation Information
Table 64. Sinopharm Description and Business Overview
Table 65. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Sinopharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 67. Sinopharm Recent Developments/Updates
Table 68. Ceva Corporation Information
Table 69. Ceva Description and Business Overview
Table 70. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Ceva Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 72. Ceva Recent Developments/Updates
Table 73. Chengdu Tianbang Biological Products Co., Ltd. Corporation Information
Table 74. Chengdu Tianbang Biological Products Co., Ltd. Description and Business Overview
Table 75. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Chengdu Tianbang Biological Products Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 77. Chengdu Tianbang Biological Products Co., Ltd. Recent Developments/Updates
Table 78. Tianjin Ruipu Biological Technology Co., Ltd. Corporation Information
Table 79. Tianjin Ruipu Biological Technology Co., Ltd. Description and Business Overview
Table 80. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Tianjin Ruipu Biological Technology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 82. Tianjin Ruipu Biological Technology Co., Ltd. Recent Developments/Updates
Table 83. Qilu Animal Health Corporation Information
Table 84. Qilu Animal Health Description and Business Overview
Table 85. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Qilu Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 87. Qilu Animal Health Recent Developments/Updates
Table 88. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Corporation Information
Table 89. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Description and Business Overview
Table 90. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 92. Guangdong Wens Dahuanong Biotechnology Co., Ltd. Recent Developments/Updates
Table 93. CAVAC Corporation Information
Table 94. CAVAC Description and Business Overview
Table 95. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. CAVAC Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 97. CAVAC Recent Developments/Updates
Table 98. Komipharm Corporation Information
Table 99. Komipharm Description and Business Overview
Table 100. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Komipharm Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 102. Komipharm Recent Developments/Updates
Table 103. Agrovet Corporation Information
Table 104. Agrovet Description and Business Overview
Table 105. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Agrovet Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 107. Agrovet Recent Developments/Updates
Table 108. Bioveta Corporation Information
Table 109. Bioveta Description and Business Overview
Table 110. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Bioveta Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 112. Bioveta Recent Developments/Updates
Table 113. Jinyu Bio-Technology Corporation Information
Table 114. Jinyu Bio-Technology Description and Business Overview
Table 115. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Jinyu Bio-Technology Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 117. Jinyu Bio-Technology Recent Developments/Updates
Table 118. Phibro Animal Health Corporation Information
Table 119. Phibro Animal Health Description and Business Overview
Table 120. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Phibro Animal Health Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 122. Phibro Animal Health Recent Developments/Updates
Table 123. Tiankang Corporation Information
Table 124. Tiankang Description and Business Overview
Table 125. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Tiankang Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 127. Tiankang Recent Developments/Updates
Table 128. Zoetis Corporation Information
Table 129. Zoetis Description and Business Overview
Table 130. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Zoetis Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 132. Zoetis Recent Developments/Updates
Table 133. Guangdong Yongshun Biological Pharmaceutical Co Ltd Corporation Information
Table 134. Guangdong Yongshun Biological Pharmaceutical Co Ltd Description and Business Overview
Table 135. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Guangdong Yongshun Biological Pharmaceutical Co Ltd Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Product
Table 137. Guangdong Yongshun Biological Pharmaceutical Co Ltd Recent Developments/Updates
Table 138. Plec Bioengineering Co., Ltd. Corporation Information
Table 139. Plec Bioengineering Co., Ltd. D

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs